• In advanced-stage HL, reduction of chemotherapy or radiotherapy after a negative interim PET scan is probably beneficial for overall survival. • Treatment escalation with rituximab after a positive ...

A rare case has been reported of diffuse large B-cell lymphoma (DLBCL) presenting initially as cold agglutinin disease (CAD). The report, published in the Kaohsiung Journal of Medical Sciences, ...

There are two types of lymphoma: Hodgkin's lymphoma and non-Hodgkin's lymphoma. Most B-cell lymphomas are non-Hodgkin's lymphoma. B-cell lymphomas come in many types. Some grow quickly and others ...

Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

China’s National Medical Products Administration (NMPA) has granted conditional approval for Hutchmed’s Tazverik ...

Primary central nervous system lymphoma (PCNSL) is a rare type of non-Hodgkin's lymphoma (NHL) confined to the nervous system. The disease is managed quite differently from other primary brain ...

At Advantage Chevrolet of Hodgkins, we strive to create a comfortable and confident buying experience for all our customers. We look forward to seeing you again soon! Sincerely, Mo Muhsen General ...

We drove from Minneapolis, MN to Hodgkins, IL because the deal was so good! They provide a well informed and quick service, and I had a positive experience at Toyota. They provide a well informed ...

A dealership's rating is based on all of their reviews, with more weight given to recent reviews. Includes reviews of Ettleson Buick GMC from DealerRater. Want to share your experience with this ...

has been granted conditional approval in China for the treatment of adult patients with relapsed or refractory ("R/R") follicular lymphoma ("FL") with EZH2 mutation who have received at least two ...

Rescue therapies of relapsed/refractory (r/r) Hodgkin’s lymphoma (HL) in the third to sixth-line provide major, yet unresolved problems. The MEPED regimen includes nuclear receptor agonists such as ...